medication-adherence
(6)
Danny Sigurdson
Danny Sigurdson is the founder and CEO of Courier Health, a New York-based technology company that builds a purpose-built patient CRM and experience platform for life sciences companies. After more than a decade in enterprise software - including a role as VP of Sales at ActionIQ and client leadership at Applied Predictive Technologies - he started Courier Health in 2020 to close the gap between specialty medicine approvals and the patients who never start or stay on treatment. The company has raised $70.5M to date, most recently a $50M Series B led by Oak HC/FT.
Matthew Loper
Matthew Loper is the co-founder and CEO of Wellth, a Los Angeles digital-health company that pays people small cash rewards for sticking to their care plans. A biological engineer from MIT turned healthcare banker and investor, he built Wellth around behavioral economics rather than technology - the idea that immediate, tangible incentives change what people actually do about their chronic conditions. Under his leadership Wellth has raised more than $73 million, including an oversubscribed $36 million Series C in 2025, and reports steep drops in hospital and emergency-room use among the high-need Medicare and Medicaid populations it serves.
Dan Rubin
Dan Rubin is President and CEO of PARx Solutions, a Burlington, Massachusetts healthtech company that runs the Prior Authorization Support System (PASS), a service that helps physician offices push prescriptions past insurer prior-authorization roadblocks at no cost to the practice. A chemical engineer by training who switched to building businesses, Rubin co-founded medication-adherence pioneer Adheris in 1993, ran it for fifteen years, then took the helm at PARx in 2012. He has spent three decades on a single problem: the gap between a doctor writing a prescription and a patient actually getting the medicine.
Yoona Kim
Yoona Kim is the co-founder and CEO of Arine, a San Francisco medication intelligence company she started in 2017 with CTO Penjit 'Boom' Moorhead. A pharmacist and health economist by training, Kim built Arine to attack one of medicine's least glamorous and most expensive problems: people getting the wrong drugs, the wrong doses, and the wrong combinations. Arine's AI platform now touches more than 25 million lives across 40-plus health plan clients, and the company says its work has cut hospitalizations by over 40% for clients while shaving care costs by double digits.
Dave Icke
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
Ogi Kavazovic
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.